Blackhawk Growth Files Quarter Ended March 31, 2021 Financial Reports

   

Vancouver, British Columbia - TheNewswire – June 1, 2021 – Blackhawk Growth Corp. BLR BLR (Frankfurt:0JJ) US BLRZF (the "Company"), is pleased to announce that the financial statements and MD&A for its third quarter ended March 31, 2021 have been filed on Sedar.

Highlights for the quarter ended March 31, 2021:

• - Blackhawk portfolio companies have recorded quarterly gross revenue of over $1,341,000

  - Portfolio Company Quarter Operations Results:

  • - Noble Hemp reports record $732,000 of gross revenue

    - Sac Pharma reports $609,000 of gross revenue

  - Spaced Food signs distribution agreement for initial production runs of cannabis infused product line

  - Leichtmind Clinic opens in Edmonton

  - NuWave Foods signs distribution agreement with Bakemark Canada for shelf stable product line

  - As at March 31, 2021, Blackhawk held $7,226,709 in current investments

  - As at March 31, 2021, NAV per share was $0.37

 

Blackhawk Growth Corp. ("Blackhawk" or the "Company") continues to review both equity and debt investment opportunities. The Company has focused its investments in the health, cannabis and CBD industries, in both Canada and the US.

 

"Our third quarter ending March 31, 2021 was a great step forward for Blackhawk but we are even more excited for what we are working on and on the verge of showcasing to our investors over the coming quarters. We continue to show growth and value to our shareholders as we work to achieve many of the substantial milestones set out for us this year. We will work to continue to execute, expand and deliver even more value to shareholders over the course of the year."

As at March 31, 2021 the Company's equity investments consist of the following:

 

Company	Cost	Fair Value
SAC Pharma Partners Inc.	$1,890,000	$3,041,350
Noble Line Inc.	532,935	1,433,177
Trip Pharma	826,852	857,675
NuWave Foods Inc.	525,586	777,000
Gaia Grow Corp.	1,050,000	750,000
Engine Media Holdings Inc.	112,507	112,507
Total Equity Investments	$4,937,880	$6,971,709

   

Short-term loans consist of the following as at March 31, 2021:

 

Loan Agreement	Principal	Fair Value
February 6, 2019	$        195,000	$        -
May 31, 2019	255,000	255,000
Total loan investments	$440,000	$255,000

About Blackhawk Growth

 

Blackhawk Growth is an investment holding looking to create substantial value for its shareholders through the acquisition and development of high growth companies. It has focused its investments in the health, cannabis and cannabidiol industries in both Canada and the United States. Its portfolio of companies includes Sac Pharma, LeichtMind Clinics, Noble Hemp, Spaced Food and NuWave Foods. Blackhawk continues to bring its investments to cash flow and is growing at an exceeding pace.

The company diligently posts updates through videos from the official company YouTube channel https://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A  

 

Please join the conversation on our Blackhawk group supporter's telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com.

 

For more information on Blackhawk, please visit our website at:

https://www.blackhawkgrowth.com/

Frederick Pels, Chief Executive Officer

(403)-991-7737

fred@blackhawkgrowth.com

Cautionary Note Regarding Forward-Looking Statement

 

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including with respect to the future prospects of the business of the Company and its portfolio companies. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Copyright (c) 2021 TheNewswire - All rights reserved.